Literature DB >> 10739709

Paget's disease of the vulva: pathology, pattern of involvement, and prognosis.

L P Parker1, J R Parker, D Bodurka-Bevers, M Deavers, M W Bevers, J Shen-Gunther, D M Gershenson.   

Abstract

OBJECTIVE: The aim of this study was to determine prognostic factors and risk factors for recurrence in patients with Paget's disease of the vulva.
METHODS: The medical records of 76 patients with a diagnosis of Paget's disease of the vulva were retrospectively reviewed. The diagnosis in each case was confirmed by reviewing the pathology. Patients were then divided into four groups by diagnosis: intraepithelial Paget's disease (IEP) (n = 46), invasive Paget's disease (IP) (n = 9), intraepithelial Paget's disease with underlying adenocarcinoma (IEPUA) (n = 13), and intraepithelial Paget's disease with a coexisting cancer (CCA) (n = 8). Comorbid conditions, location of disease, pathologic diagnosis, method of treatment, margin status, and current status of the patient were evaluated. Descriptive statistical data and univariate analysis were generated using the Statview statistical package.
RESULTS: A diagnosis of IEPUA, IP, or CCA predicted a poor survival (P = 0. 0017). Patients who had received chemotherapy or radiation as treatment had a poor survival (P < 0.0001 and 0.0002). Patients with clitoral Paget's disease had a higher incidence of death from disease (P = 0.026). When death from all causes was considered, patients treated with wide local excision (WLE) had a significantly longer survival than patients treated with other more radical treatments (P = 0.02). Risk factors for recurrence included treatment with WLE (P = 0.004).
CONCLUSIONS: Patients with IP, IEPUA, or CCA have a poorer prognosis than patients with IEP. Location of Paget's disease is important for prognosis; and patients with clitoral Paget's disease may require more aggressive treatment. WLE is associated with a higher risk of recurrence, but overall patients with WLE tend to survive longer than patients treated more radically. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10739709     DOI: 10.1006/gyno.2000.5741

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  36 in total

1.  [Extensive, painful erosion of the vulva. Extramammary Paget disease].

Authors:  A Sommer; C Appelhans; M Stücker; P Altmeyer; A Kreuter
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

Review 2.  Minimally invasive mammary Paget's disease without an underlying breast carcinoma.

Authors:  Matthew Hanna; Shabnam Jaffer; Ira J Bleiweiss; Anupma Nayak
Journal:  Virchows Arch       Date:  2013-07-14       Impact factor: 4.064

3.  Expression of vascular endothelial growth factor and basic fibroblast growth factor in extramammary Paget disease.

Authors:  Xiaoyun Xu; Ning Shao; Di Qiao; Zengjun Wang; Ningjing Song; Ninghong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Reconstruction of defects in 11 patients with penile Paget's diseases with split-thickness skin graft.

Authors:  Xiao Yun Xu; Ning Shao; Di Qiao; Quan Li; Chang Jun Yin; Li Xin Hua; Yi Ding; Ning Hong Song
Journal:  Int Urol Nephrol       Date:  2013-02-21       Impact factor: 2.370

Review 5.  A primer on extramammary Paget's disease for the urologist.

Authors:  Joon Yau Leong; Paul H Chung
Journal:  Transl Androl Urol       Date:  2020-02

6.  Paget's disease of the vulva: a clinicopathologic institutional review.

Authors:  Alberto A Mendivil; Lisa Abaid; Howard D Epstein; Mark A Rettenmaier; John V Brown; John P Micha; Marie A Wabe; Bram H Goldstein
Journal:  Int J Clin Oncol       Date:  2011-10-01       Impact factor: 3.402

7.  Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.

Authors:  Satomi Watanabe; Masayuki Takeda; Takayuki Takahama; Tsutomu Iwasa; Junji Tsurutani; Junko Tanizaki; Toshio Shimizu; Kazuko Sakai; Yoshitaka Wada; Noritaka Isogai; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  Invest New Drugs       Date:  2016-02-09       Impact factor: 3.850

8.  The role of radiation therapy for the extramammary paget's disease of the vulva ; experience of 3 cases.

Authors:  Seok-Hyun Son; Jung-Seok Lee; Yeon-Sil Kim; Mi-Ryeong Ryu; Su-Mi Chung; Sung-Eun Namkoong; Gu-Taek Han; Hee-Jeong Lee; Sei-Chul Yoon
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

9.  Extra mammary Paget's disease of the vulva.

Authors:  Debabrata Barmon; Amal Chandra Kataki; Lima Imchen; Jagannath Dev Sharma
Journal:  J Midlife Health       Date:  2012-07

10.  Extramammary Paget's disease in Korea: its association with gastrointestinal neoplasms.

Authors:  Sang Nam Yoon; In Ja Park; Hee Cheol Kim; Chang Sik Yu; Mi Woo Lee; Jai Kyoung Koh; Jin Wou Kim; Young Soo Park; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2008-06-06       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.